265 related articles for article (PubMed ID: 25755724)
1. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
2. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
Lin Y; Chen H; Hu Z; Mao Y; Xu X; Zhu Y; Xu X; Wu J; Li S; Mao Q; Zheng X; Xie L
FEBS Lett; 2013 Aug; 587(15):2467-73. PubMed ID: 23796420
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
[TBL] [Abstract][Full Text] [Related]
6. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
Lin R; Shen W; Zhi Y; Zhou Z
Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
[TBL] [Abstract][Full Text] [Related]
9. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
[TBL] [Abstract][Full Text] [Related]
10. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
[TBL] [Abstract][Full Text] [Related]
12. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
13. miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.
Liu J; Mi B; Wang Y; Shi C; Mi X; Lu Y; Yu P
Oncol Lett; 2018 Jun; 15(6):8303-8310. PubMed ID: 29928320
[TBL] [Abstract][Full Text] [Related]
14. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
Pan Y; Wang R; Zhang F; Chen Y; Lv Q; Long G; Yang K
Int J Clin Exp Pathol; 2015; 8(1):384-93. PubMed ID: 25755726
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
17. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
Li W; Yuan Y; Huang L; Qiao M; Zhang Y
Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.
Li W; Zang W; Liu P; Wang Y; Du Y; Chen X; Deng M; Sun W; Wang L; Zhao G; Zhai B
Tumour Biol; 2014 Nov; 35(11):10897-904. PubMed ID: 25085587
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
[TBL] [Abstract][Full Text] [Related]
20. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
